Table 1 Patients tested or treated for allergy and prevalence of anaphylaxis
Immunotherapy—test type | Mean age (years) | Number of patients | Number of procedures | Number of total anaphylaxis/procedures (%) | Hypertensive anaphylaxis/total anaphylaxis (%) |
|---|---|---|---|---|---|
Bee-venom | 33 | 25 | 569 | 15/569 (2.63) | 2/15 (13.33) |
Food-drug provocation test | 42 | 36 | 101 | 32/101 (3.12) | 1/32 (3.12) |
Inhalen Allergen IT (immunotherapy) | 27.7 | 177 | 3194 | 14/3194 (0.43) | 4/14 (28.57) |
Drug Injection (Omalizumab) | 44 | 86 | 468 | 1/468 (0.21) | 1/1 (100) |
Total | 36 | 324 | 4332 | 62/4332 (1.43) | 8/62 (12.90) |